Moreover, we demonstrate for the first time that IL-22BP protects from liver tumor development and that IL-22BP is produced from neutrophils in addition to dendritic cells (DCs), CD4+, and CD8+ T cells during HCC development. This evidence concerns the gene IL22RA2 and hepatocellular carcinoma.